Table 2

Detection of MSRV in the CSF of patients with MS and patients with other neurological diseases

PatientAge, yr/sexDiagnosisMS typeMS activityMS duration, yrMS treatmentMSRV ELOSA
ITMS127/MMS2° progressiveSlow progression5CorticosteroidsNegative
ITMS255/MMS1° progressiveSlow progression9None Positive
ITMS351/FMS1° progressiveSlow progression2NoneNegative
ITMS422/FMSRelapsing/remittingIn remission8None Positive
ITMS527/FMS1° progressiveSlow progression8CyclophosphamideNegative
ITMS633/MMS2° progressiveSlow progression16PRE Negative
ITMS733/FMS2° progressiveSlow progression9None Positive
ITMS825/FMSRelapsing/remittingStable3None Positive
ITMS936/FMS2° progressiveSlow progression3None Positive
ITMS1038/MMS2° progressiveSlow progression7CorticosteroidsNegative
OND137/FCerebellar atrophyNANANANANegative
OND226/FViral myelitisNANANANANegative
OND338/FViral encephalitisNANANANANegative
OND428/FViral encephalitisNANANANANegative
OND554/MViral encephalitisNANANANANegative
OND632/MGuillain–BarréNANANANANegative
OND754/FCerebrovascularNANANANANegative
OND852/FHydrocephalusNANANANANegative
OND925/F1° cerebral tumorNANANANANegative
OND1021/MEpilepsyNANANANANegative
  • NA, not applicable; PRE, previous immunosuppressive treatments.